SIRT1 and metabolic dysfunction-associated steatotic liver disease: Resveratrol is considered to be a Sirt1 enhancer, and obese mice treated with resveratrol have improved NAFLD and liver steatosis via promotion of the Sirt1/AMPK pathway [37].